ALZN
Alzamend Neuro, Inc.Company with tickers: ALZN
CIK
1677077
CUSIP
02262M605
Shares Outstanding
3,804,741
13F Activity (30d)
9 filings
8 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-04-17 | — | |
| 8-K | 2026-03-20 | — | |
| 10-Q | 2026-03-11 | 2026-01-31 | |
| 8-K | 2026-03-06 | — | |
| 10-Q | 2025-12-09 | 2025-10-31 | |
| 8-K | 2025-11-18 | — | |
| 8-K | 2025-10-14 | — | |
| 8-K | 2025-10-09 | — | |
| 8-K | 2025-09-25 | — | |
| 10-Q | 2025-09-10 | 2025-07-31 | |
| 8-K | 2025-08-01 | — | |
| 8-K | 2025-07-23 | — | |
| 10-K | 2025-07-22 | 2025-04-30 | |
| 8-K | 2025-07-09 | — | |
| 8-K | 2025-05-08 | — | |
| 8-K | 2025-04-25 | — | |
| 10-Q | 2025-03-10 | 2025-01-31 | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2025-02-28 | — | |
| 8-K | 2024-12-12 | — | |
| 10-Q | 2024-12-11 | 2024-10-31 | |
| 8-K | 2024-10-15 | — | |
| 8-K | 2024-10-03 | — | |
| 10-Q | 2024-09-11 | 2024-07-31 | |
| 8-K | 2024-07-31 | — | |
| 10-K | 2024-07-30 | 2024-04-30 | |
| 8-K | 2024-07-12 | — | |
| 8-K | 2024-07-08 | — | |
| 8-K | 2024-05-22 | — | |
| 8-K | 2024-05-15 | — | |
| 8-K | 2024-05-13 | — | |
| 8-K/A | 2024-05-10 | 2024-05-09 | |
| 8-K | 2024-05-09 | — | |
| 8-K | 2024-05-07 | — | |
| 8-K | 2024-05-01 | — | |
| 8-K | 2024-04-30 | — | |
| 8-K | 2024-03-29 | — | |
| 10-Q | 2024-03-25 | 2024-01-31 | |
| 8-K | 2024-03-22 | — | |
| 8-K | 2024-03-07 | — | |
| 8-K | 2024-02-02 | — | |
| 8-K | 2024-01-05 | — | |
| 10-Q | 2023-12-15 | 2023-10-31 | |
| 8-K | 2023-11-16 | — | |
| 8-K | 2023-10-30 | — | |
| 8-K | 2023-09-29 | — | |
| 8-K | 2023-09-22 | — | |
| 10-Q | 2023-09-13 | 2023-07-31 | |
| 8-K | 2023-09-08 | — | |
| 8-K | 2023-08-16 | — |
Showing 1–50 of 87 filings